ID   HS71L_HUMAN             Reviewed;         641 AA.
AC   P34931; A6NNB0; B0UXW8; O75634; Q2HXR3; Q8NE72; Q96QC9; Q9UQM1;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   07-APR-2021, entry version 197.
DE   RecName: Full=Heat shock 70 kDa protein 1-like;
DE            Short=Heat shock 70 kDa protein 1L;
DE   AltName: Full=Heat shock 70 kDa protein 1-Hom;
DE            Short=HSP70-Hom;
GN   Name=HSPA1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RX   PubMed=1700760; DOI=10.1007/bf00187095;
RA   Milner C.M., Campbell R.D.;
RT   "Structure and expression of the three MHC-linked HSP70 genes.";
RL   Immunogenetics 32:242-251(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=9685725; DOI=10.1093/oxfordjournals.jbchem.a022118;
RA   Ito Y., Ando A., Ando H., Ando J., Saijoh Y., Inoko H., Fujimoto H.;
RT   "Genomic structure of the spermatid-specific HSP70 homolog gene located in
RT   the class III region of the major histocompatibility complex of mouse and
RT   man.";
RL   J. Biochem. 124:347-353(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S., Campbell R.D.,
RA   Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-8; THR-268; GLY-294;
RP   MET-479; MET-493; ALA-558 AND LYS-602.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT MET-493.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-493.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   FUNCTION IN PRKN TRANSLOCATION, INTERACTION WITH PRKN, AND MUTAGENESIS OF
RP   LYS-73; LEU-396 AND 638-GLU--ASP-641.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A., Buehler E.,
RA   Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E., Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [10]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 2-386 IN COMPLEX WITH ADP AND
RP   PHOSPHATE.
RX   PubMed=20072699; DOI=10.1371/journal.pone.0008625;
RA   Wisniewska M., Karlberg T., Lehtio L., Johansson I., Kotenyova T.,
RA   Moche M., Schuler H.;
RT   "Crystal structures of the ATPase domains of four human Hsp70 isoforms:
RT   HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and HSPA5/BiP/GRP78.";
RL   PLoS ONE 5:E8625-E8625(2010).
RN   [12]
RP   VARIANT MET-493.
RX   PubMed=1356099; DOI=10.1007/bf00218042;
RA   Milner C.M., Campbell R.D.;
RT   "Polymorphic analysis of the three MHC-linked HSP70 genes.";
RL   Immunogenetics 36:357-362(1992).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of cellular
CC       processes, including protection of the proteome from stress, folding
CC       and transport of newly synthesized polypeptides, activation of
CC       proteolysis of misfolded proteins and the formation and dissociation of
CC       protein complexes. Plays a pivotal role in the protein quality control
CC       system, ensuring the correct folding of proteins, the re-folding of
CC       misfolded proteins and controlling the targeting of proteins for
CC       subsequent degradation. This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity
CC       for polypeptides is regulated by its nucleotide bound state. In the
CC       ATP-bound form, it has a low affinity for substrate proteins. However,
CC       upon hydrolysis of the ATP to ADP, it undergoes a conformational change
CC       that increases its affinity for substrate proteins. It goes through
CC       repeated cycles of ATP hydrolysis and nucleotide exchange, which
CC       permits cycles of substrate binding and release (PubMed:26865365).
CC       Positive regulator of PRKN translocation to damaged mitochondria
CC       (PubMed:24270810). {ECO:0000269|PubMed:24270810,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- SUBUNIT: Interacts with PRKN. {ECO:0000269|PubMed:20072699,
CC       ECO:0000269|PubMed:24270810}.
CC   -!- INTERACTION:
CC       P34931; O95429: BAG4; NbExp=4; IntAct=EBI-354912, EBI-2949658;
CC       P34931; O00635: TRIM38; NbExp=3; IntAct=EBI-354912, EBI-2130415;
CC   -!- TISSUE SPECIFICITY: Expressed in spermatids.
CC       {ECO:0000269|PubMed:9685725}.
CC   -!- INDUCTION: Not induced by heat shock. {ECO:0000269|PubMed:1700760}.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as
CC       the ATPase domain) is responsible for binding and hydrolyzing ATP. The
CC       C-terminal substrate-binding domain (SBD) (also known as peptide-
CC       binding domain) binds to the client/substrate proteins. The two domains
CC       are allosterically coupled so that, when ATP is bound to the NBD, the
CC       SBD binds relatively weakly to clients. When ADP is bound in the NBD, a
CC       conformational change enhances the affinity of the SBD for client
CC       proteins. {ECO:0000305|PubMed:26865365}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hspa1l/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M59829; AAA63228.1; -; Genomic_DNA.
DR   EMBL; D85730; BAA32521.1; -; mRNA.
DR   EMBL; AF134726; AAD21817.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63301.1; -; Genomic_DNA.
DR   EMBL; DQ383515; ABC88476.1; -; Genomic_DNA.
DR   EMBL; AL662834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL929592; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR388202; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034483; AAH34483.1; -; mRNA.
DR   CCDS; CCDS34413.1; -.
DR   PIR; B45871; B45871.
DR   RefSeq; NP_005518.3; NM_005527.3.
DR   PDB; 3GDQ; X-ray; 1.80 A; A=1-386.
DR   PDBsum; 3GDQ; -.
DR   SMR; P34931; -.
DR   BioGRID; 109537; 214.
DR   ELM; P34931; -.
DR   IntAct; P34931; 77.
DR   MINT; P34931; -.
DR   STRING; 9606.ENSP00000364805; -.
DR   GlyConnect; 1297; 2 N-Linked glycans (2 sites).
DR   GlyGen; P34931; 2 sites.
DR   iPTMnet; P34931; -.
DR   PhosphoSitePlus; P34931; -.
DR   SwissPalm; P34931; -.
DR   BioMuta; HSPA1L; -.
DR   DMDM; 23831140; -.
DR   UCD-2DPAGE; P34931; -.
DR   EPD; P34931; -.
DR   jPOST; P34931; -.
DR   MassIVE; P34931; -.
DR   MaxQB; P34931; -.
DR   PaxDb; P34931; -.
DR   PeptideAtlas; P34931; -.
DR   PRIDE; P34931; -.
DR   ProteomicsDB; 54956; -.
DR   TopDownProteomics; P34931; -.
DR   Antibodypedia; 13096; 393 antibodies.
DR   DNASU; 3305; -.
DR   Ensembl; ENST00000375654; ENSP00000364805; ENSG00000204390.
DR   Ensembl; ENST00000383390; ENSP00000372881; ENSG00000206383.
DR   Ensembl; ENST00000417601; ENSP00000396486; ENSG00000234258.
DR   Ensembl; ENST00000456772; ENSP00000408347; ENSG00000236251.
DR   GeneID; 3305; -.
DR   KEGG; hsa:3305; -.
DR   UCSC; uc003nxh.4; human.
DR   CTD; 3305; -.
DR   DisGeNET; 3305; -.
DR   GeneCards; HSPA1L; -.
DR   HGNC; HGNC:5234; HSPA1L.
DR   HPA; ENSG00000204390; Group enriched (testis, vagina).
DR   MIM; 140559; gene.
DR   neXtProt; NX_P34931; -.
DR   OpenTargets; ENSG00000204390; -.
DR   PharmGKB; PA29500; -.
DR   VEuPathDB; HostDB:ENSG00000204390.9; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   GeneTree; ENSGT00940000162096; -.
DR   HOGENOM; CLU_005965_2_1_1; -.
DR   InParanoid; P34931; -.
DR   OMA; CTGPSCG; -.
DR   OrthoDB; 288077at2759; -.
DR   PhylomeDB; P34931; -.
DR   TreeFam; TF105042; -.
DR   PathwayCommons; P34931; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   BioGRID-ORCS; 3305; 9 hits in 998 CRISPR screens.
DR   EvolutionaryTrace; P34931; -.
DR   GeneWiki; HSPA1L; -.
DR   GenomeRNAi; 3305; -.
DR   Pharos; P34931; Tbio.
DR   PRO; PR:P34931; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P34931; protein.
DR   Bgee; ENSG00000204390; Expressed in sperm and 182 other tissues.
DR   ExpressionAtlas; P34931; baseline and differential.
DR   Genevisible; P34931; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0002199; C:zona pellucida receptor complex; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IBA:GO_Central.
DR   GO; GO:0016887; F:ATPase activity; IBA:GO_Central.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0051787; F:misfolded protein binding; IBA:GO_Central.
DR   GO; GO:0044183; F:protein folding chaperone; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0007339; P:binding of sperm to zona pellucida; IEA:Ensembl.
DR   GO; GO:0034620; P:cellular response to unfolded protein; IBA:GO_Central.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IBA:GO_Central.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   GO; GO:0016192; P:vesicle-mediated transport; IBA:GO_Central.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   SUPFAM; SSF53067; SSF53067; 2.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Nucleotide-binding; Reference proteome.
FT   CHAIN           1..641
FT                   /note="Heat shock 70 kDa protein 1-like"
FT                   /id="PRO_0000078255"
FT   NP_BIND         14..17
FT                   /note="ATP"
FT   NP_BIND         204..206
FT                   /note="ATP"
FT   NP_BIND         270..277
FT                   /note="ATP"
FT   NP_BIND         341..344
FT                   /note="ATP"
FT   REGION          3..388
FT                   /note="Nucleotide-binding domain (NBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          396..511
FT                   /note="Substrate-binding domain (SBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   BINDING         73
FT                   /note="ATP"
FT   VARIANT         8
FT                   /note="A -> P (in dbSNP:rs9469057)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025841"
FT   VARIANT         268
FT                   /note="A -> T (in dbSNP:rs34620296)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025842"
FT   VARIANT         294
FT                   /note="D -> G (in dbSNP:rs34360259)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025843"
FT   VARIANT         479
FT                   /note="T -> M (in dbSNP:rs482145)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025844"
FT   VARIANT         493
FT                   /note="T -> M (in dbSNP:rs2227956)"
FT                   /evidence="ECO:0000269|PubMed:1356099,
FT                   ECO:0000269|PubMed:14574404, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_003820"
FT   VARIANT         558
FT                   /note="E -> A (in dbSNP:rs2227955)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025845"
FT   VARIANT         602
FT                   /note="E -> K (in dbSNP:rs2075800)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025846"
FT   MUTAGEN         73
FT                   /note="K->E: No rescue of PRKN translocation deficit in
FT                   knockout cells."
FT                   /evidence="ECO:0000269|PubMed:24270810"
FT   MUTAGEN         396
FT                   /note="L->D: No rescue of PRKN translocation deficit in
FT                   knockout cells."
FT                   /evidence="ECO:0000269|PubMed:24270810"
FT   MUTAGEN         638..641
FT                   /note="Missing: No rescue of PRKN translocation deficit in
FT                   knockout cells."
FT                   /evidence="ECO:0000269|PubMed:24270810"
FT   CONFLICT        408
FT                   /note="A -> V (in Ref. 1; AAA63228)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        416
FT                   /note="I -> M (in Ref. 7; AAH34483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="T -> P (in Ref. 1; AAA63228)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        506
FT                   /note="T -> A (in Ref. 7; AAH34483)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        627
FT                   /note="V -> M (in Ref. 2; BAA32521)"
FT                   /evidence="ECO:0000305"
FT   STRAND          9..12
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          15..24
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          27..30
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          38..41
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          44..46
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          51..53
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           55..59
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           60..63
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           65..67
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           72..75
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           83..89
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          93..99
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          102..109
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          112..116
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           118..137
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          143..148
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           154..166
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          170..176
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           177..184
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   TURN            185..188
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          195..202
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          207..215
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          218..227
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           232..251
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           255..257
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           259..275
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   TURN            276..278
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          279..290
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          293..300
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           301..307
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           309..314
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           316..325
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           330..332
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   STRAND          335..340
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           341..344
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           346..355
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   TURN            356..358
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   TURN            367..369
FT                   /evidence="ECO:0007744|PDB:3GDQ"
FT   HELIX           370..383
FT                   /evidence="ECO:0007744|PDB:3GDQ"
SQ   SEQUENCE   641 AA;  70375 MW;  A9339D7657166FF7 CRC64;
     MATAKGIAIG IDLGTTYSCV GVFQHGKVEI IANDQGNRTT PSYVAFTDTE RLIGDAAKNQ
     VAMNPQNTVF DAKRLIGRKF NDPVVQADMK LWPFQVINEG GKPKVLVSYK GENKAFYPEE
     ISSMVLTKLK ETAEAFLGHP VTNAVITVPA YFNDSQRQAT KDAGVIAGLN VLRIINEPTA
     AAIAYGLDKG GQGERHVLIF DLGGGTFDVS ILTIDDGIFE VKATAGDTHL GGEDFDNRLV
     SHFVEEFKRK HKKDISQNKR AVRRLRTACE RAKRTLSSST QANLEIDSLY EGIDFYTSIT
     RARFEELCAD LFRGTLEPVE KALRDAKMDK AKIHDIVLVG GSTRIPKVQR LLQDYFNGRD
     LNKSINPDEA VAYGAAVQAA ILMGDKSEKV QDLLLLDVAP LSLGLETAGG VMTALIKRNS
     TIPTKQTQIF TTYSDNQPGV LIQVYEGERA MTKDNNLLGR FDLTGIPPAP RGVPQIEVTF
     DIDANGILNV TATDKSTGKV NKITITNDKG RLSKEEIERM VLDAEKYKAE DEVQREKIAA
     KNALESYAFN MKSVVSDEGL KGKISESDKN KILDKCNELL SWLEVNQLAE KDEFDHKRKE
     LEQMCNPIIT KLYQGGCTGP ACGTGYVPGR PATGPTIEEV D
//
